Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2116 to 2130 of 9035 results

  1. Tucatinib with trastuzumab and oxaliplatin-based chemotherapy for untreated HER2-positive metastatic or unresectable colorectal cancer [ID6755]

    Awaiting development Reference number: GID-TA11974 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Fenfluramine for treating seizures caused by CDKL5 deficiency disorder in people 1 year and over [ID6740]

    Awaiting development Reference number: GID-TA11966 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  3. AK-OTOF for treating hearing loss caused by otoferlin gene variants [ID6735]

    Awaiting development Reference number: GID-TA11962 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  4. Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions

    Awaiting development Reference number: GID-HTG10170 Expected publication date: TBC

    HealthTech guidance
    Awaiting development

  5. Levodopa/carbidopa (ND0612) for Parkinson's Disease [ID6727]

    Awaiting development Reference number: GID-TA11954 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  6. Norucholic acid for treating primary sclerosing cholangitis [ID6583]

    In development Reference number: GID-TA11782 Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. Dabrafenib with trametinib for treating unresectable or metastatic BRAF V600 mutation positive melanoma in people 12 to 17 years [TSID12398]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  8. Dabrafenib for treating unresectable or metastatic BRAF V600 mutation positive melanoma in people 12 to 17 years [TSID12399]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  9. Allo-APZ2-CVU for treating chronic venous leg ulcers [ID6754]

    Awaiting development Reference number: GID-TA11988 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. High Definition – transcranial Electrical Stimulation (HD-tES) for fibromyalgia

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  11. Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) system for pancreatic cystic neoplasms and neuroendocrine tumours

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  12. Helium plasma coagulation for treating Respiratory Papillomatosis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  13. Transnasal Panendoscopy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  14. Chemical Component Separation

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  15. Intralesional cryotherapy for keloid scars

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation